Novartis India Ltd

Novartis India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novartis India Ltd

₹ 694 -0.76%
29 Nov - close price
novartis.in BSE: 500672 NSE : NOVARTIND
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Therapeutic Segments
The company's pharmaceutical business is focused on bone & pain, calcium portfolio, gynecology and neurosciences. Its generics business is focused on gynecology, anti-TB and anti-infectives. [1]

Website BSE NSE
  • Market Cap ₹ 1,715 Cr.
  • Current Price ₹ 694
  • High / Low ₹ 909 / 537
  • Stock P/E 22.4
  • Book Value ₹ 284
  • Dividend Yield 1.44 %
  • ROCE 15.1 %
  • ROE 13.7 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of -7.65% over past five years.
  • Company has a low return on equity of 7.56% over last 3 years.
  • Earnings include an other income of Rs.54.0 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
96 94 99 98 104 99 98 121 102 80 76 91 79
86 97 84 90 97 92 93 89 85 73 67 73 62
Operating Profit 10 -3 15 8 7 7 6 32 16 8 9 17 17
OPM % 11% -3% 15% 8% 7% 7% 6% 26% 16% 10% 12% 19% 21%
6 8 12 6 6 6 -35 27 7 8 16 12 17
Interest 2 2 3 2 2 1 0 0 0 0 0 0 1
Depreciation 3 3 3 3 3 3 1 1 1 1 2 2 1
Profit before tax 11 1 22 10 9 8 -31 57 21 14 23 28 32
Tax % 32% 204% 56% 36% 24% 24% 25% 7% 14% 47% -7% 27% 27%
8 -1 10 6 7 6 -23 52 18 8 25 20 24
EPS in Rs 3.05 -0.29 3.93 2.54 2.84 2.57 -9.47 21.21 7.43 3.08 10.13 8.21 9.59
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
842 901 859 870 690 656 564 491 438 381 400 379 326
698 810 861 874 656 631 570 478 426 355 373 314 274
Operating Profit 144 90 -1 -4 34 25 -6 12 12 27 27 65 51
OPM % 17% 10% -0% -0% 5% 4% -1% 2% 3% 7% 7% 17% 16%
84 83 95 101 207 71 172 78 36 33 -17 58 54
Interest 1 0 0 0 0 1 6 2 6 8 5 2 2
Depreciation 3 4 4 4 3 4 3 3 13 12 10 6 6
Profit before tax 225 169 90 93 237 92 158 86 29 40 -4 115 98
Tax % 32% 29% -10% 15% 16% 38% 50% 40% 65% 48% 3% 10%
152 120 99 79 198 57 78 52 10 21 -4 103 77
EPS in Rs 47.56 37.46 30.83 24.75 62.04 20.33 31.74 20.97 4.08 8.46 -1.51 41.86 31.01
Dividend Payout % 21% 27% 32% 40% 16% 49% 32% 48% 245% 118% -663% 113%
Compounded Sales Growth
10 Years: -8%
5 Years: -8%
3 Years: -5%
TTM: -22%
Compounded Profit Growth
10 Years: -2%
5 Years: 9%
3 Years: 115%
TTM: -24%
Stock Price CAGR
10 Years: 4%
5 Years: 0%
3 Years: 2%
1 Year: 3%
Return on Equity
10 Years: 8%
5 Years: 6%
3 Years: 8%
Last Year: 14%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 16 16 16 16 16 14 12 12 12 12 12 12 12
Reserves 802 884 945 986 1,178 906 721 747 708 699 679 763 690
0 0 0 0 0 0 0 0 68 62 24 22 8
216 241 241 244 239 230 377 223 289 229 242 186 160
Total Liabilities 1,034 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 871
10 10 8 8 6 6 5 15 76 64 24 19 8
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
1,023 1,131 1,194 1,238 1,426 1,144 1,106 967 1,001 938 934 964 863
Total Assets 1,034 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 871

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
75 7 -5 -60 57 -41 161 -194 -23 -69 39 45
-43 -16 22 719 -630 424 69 274 56 95 87 -153
-37 -37 -38 -38 -39 -332 -268 -30 -41 -37 -36 -30
Net Cash Flow -5 -46 -20 622 -612 51 -38 50 -9 -11 90 -139

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 30 33 33 35 27 23 28 34 31 37 41 35
Inventory Days 93 108 96 103 92 104 84 111 117 119 117 99
Days Payable 115 117 100 98 89 87 158 168 145 137 148 108
Cash Conversion Cycle 8 24 29 40 30 40 -45 -23 3 19 10 26
Working Capital Days 285 317 353 6 -35 -14 -99 7 9 75 -18 -33
ROCE % 30% 20% 10% 9% 22% 9% 17% 12% 5% 6% 6% 15%

Shareholding Pattern

Numbers in percentages

Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68%
0.05% 0.06% 0.06% 0.03% 0.09% 0.12% 0.14% 0.17% 0.17% 0.17% 0.23% 0.32%
0.79% 0.78% 0.84% 0.78% 0.78% 0.77% 0.78% 0.77% 0.77% 0.77% 0.75% 0.52%
28.48% 28.48% 28.43% 28.51% 28.46% 28.43% 28.41% 28.37% 28.37% 28.38% 28.34% 28.47%
No. of Shareholders 41,44241,57243,78445,14144,64044,37143,99643,27542,62241,94743,34343,992

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports